Search by Drug Name or NDC
NDC 00054-0389-25 Methamphetamine Hydrochloride 5 mg/1 Details
Methamphetamine Hydrochloride 5 mg/1
Methamphetamine Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hikma Pharmaceuticals USA Inc.. The primary component is METHAMPHETAMINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Methamphetamine is used as part of a treatment program to control symptoms of attention deficit hyperactivity disorder (ADHD; more difficulty focusing, controlling actions, and remaining still or quiet than other people who are the same age) in children. Methamphetamine is also used for a limited period of time (a few weeks) along with a reduced calorie diet and an exercise plan for weight loss in obese people unable to lose weight. Methamphetamine is in a class of medications called central nervous system stimulants. It works by changing the amounts of certain natural substances in the brain.
Related Packages: 00054-0389-25Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Methamphetamine
Product Information
| NDC | 00054-0389 |
|---|---|
| Product ID | 0054-0389_e3885555-8e95-4377-8583-99abc1f5b5f5 |
| Associated GPIs | 61100030100305 |
| GCN Sequence Number | 005014 |
| GCN Sequence Number Description | methamphetamine HCl TABLET 5 MG ORAL |
| HIC3 | J5B |
| HIC3 Description | ADRENERGICS, AROMATIC, NON-CATECHOLAMINE |
| GCN | 19932 |
| HICL Sequence Number | 002067 |
| HICL Sequence Number Description | METHAMPHETAMINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Methamphetamine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Methamphetamine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/1 |
| Substance Name | METHAMPHETAMINE HYDROCHLORIDE |
| Labeler Name | Hikma Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Amphetamine Anorectic [EPC], Amphetamines [CS], Appetite Suppression [PE], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Increased Sympathetic Activity [PE] |
| DEA Schedule | CII |
| Marketing Category | ANDA |
| Application Number | ANDA203846 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00054-0389-25 (00054038925)
| NDC Package Code | 0054-0389-25 |
|---|---|
| Billing NDC | 00054038925 |
| Package | 100 TABLET in 1 BOTTLE (0054-0389-25) |
| Marketing Start Date | 2016-12-06 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 6.82872 |
| Pricing Unit | EA |
| Effective Date | 2021-07-21 |
| NDC Description | METHAMPHETAMINE 5 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4 |
| Classification for Rate Setting | G |
| As of Date | 2022-07-13 |